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Abstract Cis-acting polymorphisms that affect gene
expression are now known to be frequent, although the extent
and mechanisms by which such variation affects the human
phenotype are, as yet, only poorly understood. Key signa-
tures of cis-acting variation are differences in gene expres-
sion that are tightly associated with regulatory SNPs or
expression Quantitative Trait Loci (eQTL) and an imbalance
of allelic expression (AEI) in heterozygous samples. Such
cis-acting sequence differences appear often to have been
under selection within and between populations and are also
thought to be important in speciation. Here we describe the
example of lactase persistence. In medical research, variants
that affect regulation in cis have been implicated in both
monogenic and polygenic disorders, and in the metabolism
of drugs. In this review we suggest that by further under-
standing common regulatory variations and how they inter-
act with other genetic and environmental variables it will be
possible to gain insight into important mechanisms behind
complex disease, with the potential to lead to new methods of
diagnosis and treatments.
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Introduction
Understanding the mechanisms behind phenotypic varia-
tion is a key aim in human genetics, particularly in relation
to disease and disease susceptibility. With approximately 1
difference per 1,000 nucleotides between any two human
individuals chosen at random, deciphering which variants
have function is a vital objective in modern day genetic
research. The availability of a much larger range of
methodologies has led to a bias towards studies focused on
coding sequence variation. The functioning of each gene
however, is determined not only by the protein itself but is
also governed by spatiotemporal expression patterns, with
differences in the timings and levels of expression of genes
potentially altering phenotype. Considerable differences in
gene expression have been demonstrated both between
individuals and populations (Cheung et al. 2005; Stranger
et al. 2005, 2007) and it has long been speculated that much
of the phenotypic diversity within and between species is
due to genetically determined differences in gene expres-
sion levels (King and Wilson 1975; Skelly et al. 2009).
Gene expression is controlled by genetic factors, acting
both in cis and in trans, epigenetic factors and environ-
mental influences (Stranger et al. 2007) with many com-
plex heritable traits controlled by both cis and trans acting
loci (Cheung et al. 2010; Wang et al. 2008). Mutations in
cis-regulatory elements (including promoters, enhancers,
silencers and insulators) can disrupt or enhance the binding
of transcription factors and alter the state of gene expres-
sion of single genes. Transposable elements also appear to
have influenced mammalian regulation with the creation of
repeat associated binding sites (Bourque et al. 2008; Ku-
narso et al. 2010). Heterozygotes for regulatory SNPs
display intermediate levels of expression and show allelic
expression imbalance (AEI), one of the hallmarks of cis-
acting variation (Fig. 1). Functional mutations in tran-
scription factors (in trans), in contrast, are often pleiotropic
because of modified binding to multiple transcription factor
binding sites (TFBS), which may alter the expression of
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many genes. Trans-acting variants involved in gene
expression operate equally on both chromosomes so no
imbalance of allelic expression is seen (Fig. 1c).
TFBSs are usually 6–20 base pairs in length (Lapidot
et al. 2008) and imprecise; one transcription factor may
bind to a range of similar sequence TFBSs. Although these
sites can differ, there are clear biases in the expectations of
bases that appear at each binding site position, probabilities
of which can be displayed using position weight matrices
(PWMs) (Lapidot et al. 2008; Stormo 2000). Because of
this flexibility in specificity, mutations in binding sites may
not alter binding and thus have no phenotypic effect. In
other instances, a nucleotide change within a binding site
leads to an altered binding affinity or even the loss or gain
of a TFBS (Doniger and Fay 2007), and it is these varia-
tions which have the potential to alter gene expression and
consequently affect phenotype. Since transcription factors
show different gene expression profiles in different cell
types, nucleotide changes in binding sites will have dif-
ferent implications in different cells. This review will focus
primarily on current understanding of the effects of cis-
regulation on the human phenotype. Note that mutations
which affect copy number, RNA stability or splicing also
affect transcript levels in a cis-acting manner, but are not
specifically considered in this review.
Methods of detecting cis-acting variation
Until high-throughput methods for detecting gene expres-
sion were developed, techniques for the evaluation of gene
expression were limited to single gene analyses. Semi-
quantitative reverse transcription PCR and real time PCR
were commonly used to quantify levels of expression and
could be adapted to measure individual allelic transcripts of
a gene by making use of marker SNPs located in the exons.
The allelic transcripts could be distinguished by a variety
of methods including direct sequencing and RFLP primer
extension assays (Loh et al. 2010; Wang et al. 1995, 1998).
By comparing the relative expression levels of allelic
transcripts within a heterozygous sample, cis-acting dif-
ferences or ‘allelic expression’ can be measured (AE),
while internally controlling for environmental and trans-
acting factors (Pastinen and Hudson 2004; Verlaan et al.
2009). This approach also detects epigenetic effects such as
imprinting (Pollard et al. 2008; Verlaan et al. 2009)
although in this case, analysis of parents would show
exclusively maternal or paternal inheritance.
In the mid 1990’s, it became possible to measure the
expression levels of thousands of genes simultaneously and
various approaches have since been developed which uti-
lise hybridisation or sequence based methods with the
capability of measuring complete transcriptomes (Bertone
et al. 2004; Cheng et al. 2005). Microarrays exploit
hybridisation methods and fluorescence, and kits using
oligonucleotide sequences or cDNA probes were made
available commercially that allow mapping of patterns of
expression but measure both allelic transcripts of a gene
simultaneously. However by demonstrating association of
SNPs near to the gene with expression levels (Stranger
et al. 2005), it was possible to provide evidence of, and
map, cis-acting regulatory loci. Such ‘eQTL mapping’ is a
way of determining the relationship between the genome
and transcriptome and has led to the observation that cis-
eQTLs are a common cause of variation in gene expression
(Stranger et al. 2005, 2007). The availability of bead chips
has enabled genome-wide allelic expression studies by
allowing the comparison of SNP allele ratios in expressed
RNA transcripts normalized against genomic DNA het-
erozygote ratios (Ge et al. 2009).
The manipulation of next generation sequencing (NGS)
methods to measure gene expression levels (and also for
the detection of alternative splicing or novel transcripts)
has been one of the most striking advances in transcripto-
mics in recent years. RNA-sequencing (RNA-Seq) of a
population of RNA (total or fractionated) involves
Fig. 1 Heterozygous allelic imbalance through cis-acting regulatory
variation. a A mutation in a proximal promoter may prevent
transcription factor binding altering expression of the allelic tran-
script. Marker SNPs (shown here as black/white circles) can be used
to determine transcript ratios. b A mutation in a distal enhancer site
may prevent combinatorial binding and affect transcription levels. c A
mutation in trans will affect both alleles equally and no AEI will be
seen
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converting the RNA to cDNA fragments attached to
adapters and direct sequencing using NGS methods. The
transcripts are then aligned or assembled to produce a map
of the transcriptome and expression levels for each gene
(Wang et al. 2009). RNA-Seq is able to describe previously
unknown or novel sequences and discover new variants in
transcribed sequences. Importantly it is able to detect allele
specific expression although, as with all AE methods that
rely on heterozygous markers within exons, the number of
SNPs within the coding regions and the number of indi-
viduals who are heterozygous for any particular gene
transcript can be restrictive. A recent study that utilised
both unspliced primary transcripts as well as mRNA,
identified over 50% more genes showing AE differences
than if exonic SNPs alone were used (Verlaan et al. 2009).
An important limitation in studying cis-regulation gen-
ome-wide is that analysis of the transcriptome is ultimately
dependent on the cell type and developmental stage. So far
the majority of genome wide studies have used a small
number of cell lines giving a very restrictive representation
of tissue specific gene transcripts. Because of the density
and coverage of the HapMap SNP data and DNA avail-
ability from the lymphoblastoid cell lines (LCL) for Hap-
Map individuals, the majority of regulatory studies have
been conducted in LCL cells (see for example (Ge et al.
2009; Stranger et al. 2005, 2007). Concerns have been raised
about the use of LCLs in determining allelic expression,
because of changes that may have occurred in cell culture
(Gimelbrant et al. 2007; Pastinen et al. 2004) although it has
since been reported that this is not a significant source of
spurious AE association and that it is possible to correct for
the confounding effect (Ge et al. 2009).
Where it is possible to compare allelic expression across
cell types, further information on the complexity of the
regulation of gene expression can be gained. Tissue spec-
ificity of AE has been documented in mice (Campbell et al.
2008) and differences in allelic expression have been
demonstrated between human brain regions (Buonocore
et al. 2010). Genome wide comparison of AE in human cell
lines appears to show the same effect and indicates an
enrichment of gene networks associated with immunolog-
ical disease in LCLs, and musculoskeletal disease in human
osteoblast cells with several of these genes implicated in
multifactorial disease (Verlaan et al. 2009). A study of
gene expression across three cell types estimated 69–80%
of regulatory variants were cell type specific (Dimas et al.
2009) and recent work by Ernst and colleagues (using
chromatin profiling across nine cell types) suggests disease
associated SNPs are frequently found within enhancer
elements and appear to be active in specific and relevant
cell types (Ernst et al. 2011). Both of these studies clearly
demonstrate the importance of examining expression
across multiple cell types in future studies.
Locating putative functional elements and variants
In the absence of suitable cell lines, another method of
identifying potential functional regulatory variants is to
look at conservation across species (Goode et al. 2010;
Lomelin et al. 2010). Goode and colleagues were able to
show that a very large percentage of SNPs in conserved
regions, identified by evolutionary rate profiling, were in
non-coding regions under evolutionary constraint (Goode
et al. 2010). By making use of a transgenic mouse embryo
system, Pennachio et al. further characterised some of the
conserved sequences and used this information to rank and
map potential enhancers across the human genome (Pen-
nacchio et al. 2006).
However as increasing evidence suggests that many cis-
regulatory sequence regions (and many of the non-coding
alleles under purifying selection (Asthana et al. 2007)) may
be poorly conserved (Burton et al. 2007; Kunarso et al.
2010; Pennacchio and Visel 2010; Yokoyama et al. 2011),
an alternative method is to identify regions of the genome
with a high density of TFBSs (proposed to be more likely
functional than regions with single TFBSs due to the for-
mation of transcription factor complexes) (Yu et al. 2007;
Zinzen et al. 2009). By selecting relevant or interracting
TFs for a set of tissues, a bioinformatics study that fol-
lowed this approach detected genes that appeared to be
regulated by different TF clusters/complexes in different
tissues and observed that conserved regulatory modules are
more likely to regulate essential genes than non-conserved
modules (Yu et al. 2007). The recent development of
bioinformatics tools, such as COMPASSS (COMplex
Pattern of Sequence Search Software) (Maccari et al.
2010), provide a further resource in the detection of puta-
tive functional cis-acting elements in the genome. As the
empirical datasets with binding, sequence and expression
data are rapidly expanding, it is likely that the sensitivity of
these methods will increase and provide further insight into
the complexities of cis-acting regulation.
Methods to detect function of cis-acting regulatory
regions
To identify or confirm particular functional elements in the
genome, including promoters, enhancers, silencers and
insulators, a number of empirical approaches can be taken.
These range from methods involving transfection of
reporter constructs to those examining properties of chro-
matin. For example, by immunoprecipitating from chro-
matin, ChIP-chip experiments are able to localize binding
sites for any protein of interest. Approaches to identify
active gene transcription include the Haplochip method
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which exploits the fact that the amount of chromatin-bound
active Pol II RNA polymerase enzyme is related to the
transcriptional activity of the corresponding gene, so that
differences in active Pol II loading between the two alleles
in a heterozygous sample provides a measure of allele-
specific gene expression (Knight et al. 2003). However to
assess the effect of particular nucleotide substitutions it is
more usual to conduct gel shift assays, often in combina-
tion with antibodies, to detect protein binding (for example
Hultman et al. 2010), or transfections of constructs in
which the relevant mutations have been introduced (for
example Jensen et al. 2011; Troelsen et al. 2003). Both
these methods have the limitation that they reflect effects in
vitro which may not well replicate what happens in vivo,
where for example different proportions of transcription
factors may be present.
Cis-acting variation and evolution
The existence of conserved non-coding elements (CNE) has
been helpful in identifying tissue specific enhancers (Lee
et al. 2011; Pennacchio et al. 2006) as described above.
However, regulatory elements may be lineage specific and
also show evidence of rapid evolution in some groups, as
described, for example, in Teleost fishes (Lee et al. 2011)
where a high level of loss is associated with a whole gen-
ome duplication. It is now evident that cis-regulatory
mutations have been important in the adaptive evolution of
populations both in terms of speciation and environmental
adaptations or adaptive divergence of particular species
(Fay and Wittkopp 2008; Bourque et al. 2008; Kunarso
et al. 2010; He et al. 2011; Lee et al. 2011; Yokoyama et al.
2011). It has been proposed that certain adaptations or traits
such as those involving immune responses, behaviour,
reproduction and development and also gain of function
mutations are more likely to occur through cis-regulatory
mutations where transcription can be ‘fine-tuned’ to meet
demands (Wray 2007). While a non-synonymous coding
mutation usually affects the protein regardless of where or
when it is expressed, a mutation in a cis-regulatory element
has the potential to affect gene expression during a partic-
ular stage of development or in a specific cell type. Positive
or adaptive selection is potentially able operate more effi-
ciently on cis-regulatory regions than coding regions
because single nucleotide changes are less likely to have an
all or nothing effect, while at the same time they are usually
co-dominant (i.e heterozygotes show intermediate pheno-
type) and therefore directly available to natural selection in
the presence of the ancestral allele (Wray 2007). Repeat
associated binding sites often appear to be lineage specific
leading to the possibility that many binding sites have
arisen fairly recently and rewired regulatory pathways.
Common cis-variation and selection in human evolution
It was first suggested some time ago that the differences
between the proteins of the chimpanzee and human were
insufficient to explain the differences in phenotypic char-
acteristics and that differences in regulation could play an
important role (King and Wilson 1975). One example of
sequence changes in cis-regulatory regions in the human/
chimpanzee divergence involves a 68 bp tandem repeat
element 1,250 bp upstream from the start of transcription
of PDYN (which encodes a neuropeptide with roles in
cognition) for which there is evidence of function. Non-
human primates have only one copy while human haplo-
types contain between 1 and 4 copies (Rockman et al.
2005). Multiple other upstream polymorphisms are also
thought to influence the expression of PDYN, some in a
cell-specific or sex-specific manner (Babbitt et al. 2010). A
selection of examples of polymorphic cis-regulatory vari-
ants with fairly certain phenotypic effect in humans are
shown in Table 1. Several of these variations are involved
in the inflammatory response, while others are involved in
disease resistance or susceptibility and dietary adaptation.
Lactase persistence; an example of dietary adaptation
through cis-acting regulatory polymorphisms
The ongoing expression of lactase into adulthood, in some
humans but not others, is one of the classic examples of an
environmental adaptation. The expression of lactase
enzyme in the intestine is necessary for the breakdown of
lactose, the main carbohydrate in milk. As milk is the
primary source of nutrition for all newborn mammals,
functional lactase enzyme is critical for survival (excluding
the Pinnepedia where milk has a high fat content and low
lactose content) until other food sources can be consumed.
Usually lactase is down-regulated after weaning (termed
‘lactase non-persistence’) although approximately 35% of
the human population continue to produce lactase into
adulthood (‘lactase persistence’) (Ingram et al. 2009a). The
ability to use milk as a source of nutrition without digestive
complications is thought to have put some people at a
selective advantage, with the expansion of this genetic trait
reflecting the onset of animal domestication and milking
over the last 10,000 years (Ingram et al. 2009a). It was first
directly demonstrated that the inter-individual differences
in expression of lactase were cis-acting using allelic
expression techniques (Wang et al. 1995, 1998). Extended
sequencing identified a C/T SNP 13,910 base pairs
upstream of the lactase gene (see Fig. 2) for which the T
allele was 100% associated with lactase persistence in
Finns (Enattah et al. 2002), and also directed differential
levels of promoter construct expression (Lewinsky et al.
16 HUGO J (2011) 5:13–23
123
Table 1 Examples of cis-acting functional variants thought to affect human phenotypic characteristics
Gene Variant Effect Phenotype/disease risk Methods to
show function
Reference(s)




Associated with alcoholism Transfections Pochareddy and
Edenberg
(2011)
DARC T-46C Impairs promoter
activity
Resistance to malaria Transfections Tournamille
et al. (1995)
FMO3 Promoter haplotypes (1 kb) ‘2’ 8 fold increase in
activity, ‘8’ & ‘15’
loss of activity




IL6 Promoter haplotype variation Altered IL6
expression
Various disease associations Transfections Terry et al.
(2000)
IL10 Promoter haplotype variation TA2 haplotype has
higher levels of
IL10 expression
High risk TA2 haplotype
associated with trachoma
susceptibility
AE Natividad et al.
(2008)
IL13 C-1055T T increases IL13
expression
Association with asthma & allergy Gel shift assay van der Pouw
Kraan et al.
(1999)








LTC4S A-444C Altered expression Linked to aspirin associated




MUC5B Several promoter haplotypes Altered MUC5B
expression
Underrepresentation of low


















SHH Several mutations 1mb
upstream in enhancer within
LMBR1 (& in other species)







UGT1A1 (TA)n repeat in TATA box (TA)7 (low
expression)
Gilberts syndrome, adverse drug
reactions




Altered expression Possible links to oxazepam
glucuronidation, breast and
prostate cancer risk
Transfections Sun et al.
(2010)
Fig. 2 The lactase enhancer region. a The LCT enhancer is located
upstream in intron 13 of MCM6. Multiple derived alleles are found
clustered in this small region, indicated by yellow boxes. Dots above
the variant sites show the 4 SNPs that have been associated with LP,
or shown to have function so far. The position of this region upstream
of LCT is shown above the sequence. b Known transcription factor
binding sites (see Lewinsky et al. 2005; Jensen et al. 2011) in the
enhancer region are shown in relation to the 4 LP associated SNPs
(black dots) with approximate positions relative to LCT indicated
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2005; Troelsen et al. 2003) in CaCo2 cells, a colon carci-
noma cell line that expresses lactase. This allele is found at
high frequency (in many European populations) on an
exceptionally long haplotype, indicative of directional
selection (Bersaglieri et al. 2004; Poulter et al. 2003).
It was subsequently found however that this particular
mutation was not responsible for the ongoing expression of
lactase in all humans (Mulcare et al. 2004) and at least
three further functional alleles (and likely more (Itan et al.
2010)) appear to have been selected independently (Enat-
tah et al. 2008; Imtiaz et al. 2007; Ingram et al. 2007;
Tishkoff et al. 2007). These SNPs are clustered in a region
that acts as an enhancer for the lactase gene (Lewinsky
et al. 2005) with several known transcription factor binding
sites (Jensen et al. 2011; Lewinsky et al. 2005), outlined in
Fig. 2. Interestingly, several of these SNPs can occur in a
single ethnic group providing evidence in humans of a ‘soft
selective sweep’ of the kind described below (Ingram et al.
2009b). Since Caco-2 is the only human cell line known to
express significant levels of lactase, the genome wide
expression studies so far have missed the LCT quantitative
trait loci, which highlights the fact that there must be many
more similar cis-acting variants to be discovered once more
cell lines/tissues are used in genome wide expression
studies.
Cis-regulation and selection for disease resistance,
disease susceptibility and differing drug responses
Domestication also exposed populations to new pathogens
and the resulting villages and towns facilitated the spread
of diseases (Diamond 2002; Wolfe et al. 2007). Malaria is
the disease for which there is the most evidence for human
adaptation against infectious agents, in that a very large
number of associations have been described with gene
variants that confer resistance. Although many of these
variants affect protein sequences, one of these mutations is
a cis-acting regulatory mutation that disrupts the binding of
the GATA1 transcription factor, preventing the expression
of the Duffy blood group chemokine receptor (DARC) in
erythrocytes (Tournamille et al. 1995). As the DARC
protein is the usual point of entry for the malarial parasite
Plasmodium vivax, individuals homozygous for the muta-
tion are resistant to the disease and in fact selection has
been so strong that most individuals in the endemic areas
are homozygous for the mutation. This particular example
is illustrative of the ability of a cis-acting mutation to cause
a change in gene expression in one cell type only without
affecting expression levels elsewhere, as individuals with
the mutation still express the DARC protein in other cell
types (Chaudhuri et al. 1995) and show no adverse health
affects.
Variation in the number of TA repeats in the TATA box
for the enzyme UDP-glucuronosyltransferase 1A1
(UGT1A1) which catalyses the conjugation of glucuronic
acid to bilirubin, and also a number of pharmaceutical
drugs, has been shown directly by transfection studies to
affect expression of UGT1A1, and is associated with bili-
rubin level as well as with drug sensitivity (Borlak and
Klutcka 2004; Bosma et al. 1995). Interestingly, the geo-
graphic distribution of the low activity alleles (which are
proposed to be protective against various infectious blood
pathogens) in Africa, suggest that this is another poly-
morphism that might have been under selection by malaria
(Horsfall et al. 2011b) and is an example of polymorphism
in which there are both costs and benefits, since while
bilirubin is potentially toxic, moderately high levels seem
to be beneficial to respiratory and cardiac health (Horsfall
et al. 2011a). There are several genes involved in the
metabolism of drugs, for which there is evidence for the
effect of cis-variation in their expression (for two excellent
reviews see (Hines et al. 2008; Johnson et al. 2005)). There
are also many other examples of TATA box polymor-
phisms, some of which are involved in disease (see Sav-
inkova et al. 2009).
Indeed there are now many examples in which promoter
and other regulatory variants cause or modify Mendelian
disease or disorders. Several examples come from the
globin loci and have been reviewed by others (see Sanka-
ran et al. 2010). One example of particular interest involves
enhancer mutations in a cis-regulatory element upstream of
the SHH gene that lead to aberrant developmental expres-
sion and incorrect limb bud formation resulting in extra
digits in humans and certain other species. Several different
causal mutations are located close together in this long-
range (1 Mb upstream) enhancer, which is, as in the case of
lactase, in an intron of another gene (Gurnett et al. 2007;
Lettice et al. 2003).
Genome-wide association studies and cis-acting
regulation
Genome-wide association studies to find the genetic com-
ponents of multifactorial disease are able to locate regions
along the genome that contain variants that underlie dis-
eases or phenotype and it is now evident that many of these
will be regulatory. Recent developments are providing
more precision in mapping of the causal loci (Andrew et al.
2008), but at present bioinformatics methods are lacking
power to identify the likely functional variants or mecha-
nism behind the differences in gene expression levels. With
the complication of different transcription factor com-
plexes initiating transcription in different cell types, it is
currently not possible to predict whether a non-coding
18 HUGO J (2011) 5:13–23
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variant will be functional without experimental evidence in
an appropriate environment. However identification of
variants in binding sites that are likely to alter gene
expression and cause disease is becoming more attainable
on a genome-wide scale, with the use of computational
prediction methods which depend on accumulation of
published experimental data (Lapidot et al. 2008). For
example, in S. cerevisiae, it appears that not all nucleotide
substitutions are equal; a substitution involving guanine
appears to have more of an effect than a substitution of
adenine (Lapidot et al. 2008) and although this effect has
not yet been shown in the human genome, it may be that
similar computational methods will eventually be able to
predict the variants in regulatory elements that are more
likely to alter transcription in humans and thus cause dis-
ease or disease susceptibility. It may also be the case that
multiple independent mutations, (perhaps closely located
as in the case of the enhancer polymorphisms of SHH and
LCT), influence disease susceptibility and resistance and
are potentially good candidates for multifactorial disease.
These are characteristically harder to identify than single
mutations because they may not be efficiently tagged by
the SNPs tested, and this could account for some of the
‘missing heritability’ in genome wide association studies.
Since regulatory elements interact with trans-acting
factors they are often the target of environmental response
and can by definition be regulated, there is potential for
manipulating gene expression as a method of disease pre-
vention or therapy. A good example of this comes from the
haemoglobins, in which attempts have been made to up-
regulate fetal haemoglobin (HBF) to compensate for the
defective adult haemoglobin in haemoglobinopathies, as
reviewed in (Sankaran et al. 2010). The switch from fetal to
adult globin expression is under relatively tight develop-
mental control, for which many of the cis- and trans-acting
interactions are now known, but show inter-individual
differences, as well as non-genetic alterations (e.g stress
response). With the understanding of the key players
involved in this regulation it is now possible to work on
and refine methods of manipulating the expression of HBF.
Since changes in gene expression are an important
source of evolutionary adaptation, Kudaravalli and col-
leagues combined eQTL data from HapMap lymphoblas-
toid cell lines with a haplotype based method for detecting
signals of selection (Kudaravalli et al. 2009). They found a
strong overlap between signals, particularly for genes
known to be associated with diseases with immunological
involvement, such as susceptibility to HIV infection, as
might be expected for LCLs. Several recent genome wide
disease association studies have attempted to overlap GWA
signals with eQTLs or variants that may be involved in the
regulation of genes (either through imprinting or allelic
variability) (Heid et al. 2010; Kong et al. 2009; Nica et al.
2010; Voight et al. 2010) and statistical methods are being
developed, that take into account LD, to make these mat-
ches more robust. However further studies to determine
function are necessary and analysis of data from compa-
rable studies in multiple cell lines may provide further
evidence on the function of cis-regulatory variants under
selection or those associated with disease.
Parallel evolution due to cis-acting variation: soft
selective sweeps
Care must be taken not to over-simplify the characteristics
of selection (Przeworski et al. 2005), and it has recently
been proposed that hard sweeps, have been too infrequent
in the human population over the last 250,000 years to
have been responsible for much human genetic adaptation
(Hernandez et al. 2011). Populations can adapt to new
environmental pressures via multiple mutations, with
similar phenotypic effect that arise independently. If sev-
eral mutations with similar effect are selected in parallel,
by what has been termed a ‘soft selective sweep’ (Her-
misson and Pennings 2005; Pennings and Hermisson
2006a, b), they may, for example, all get to intermediate
frequencies in one population or go to fixation in different
populations. Soft selective sweeps can occur from standing,
new or migration of mutations and as human population
densities have increased over time, so has the likelihood of
parallel adaptation occurring (Ralph and Coop 2010). It has
also been noted that a number of more recent human
adaptations have involved repeated mutations at small
mutational target sites and often occur in relatively small
geographic areas, while older adaptations from single
changes are more widely spread (Ralph and Coop 2010).
Changes to the pigmentation in fruit flies (Gompel et al.
2005; Jeong et al. 2008), pelvic reduction in freshwater
sticklebacks (Chan et al. 2010) and lactase persistence in
humans (Enattah et al. 2008; Ingram et al. 2007, 2009b;
Tishkoff et al. 2007) are all well described cases of parallel
evolution where multiple independent cis-regulatory chan-
ges are responsible for a convergent phenotype. Currently,
most standard tests for selection in humans are based on the
‘hard sweep model’ (Smith and Haigh 1974) where one allele
under selection rises quickly in frequency and is conse-
quently found at high frequency on an extended haplotypic
background (Sabeti et al. 2002, 2007; Voight et al. 2006;
Zhang et al. 2006). These tests may miss the diversity
characteristic of soft sweeps in populations where there are
multiple alleles with the same functional effect which are
likely to occur on distinct haplotype backgrounds. Further-
more recent selection may have increased the allele fre-
quency of older ‘standing’ variation which will also have
greater haplotype diversity (Ralph and Coop 2010).
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The frequency and significance of cis-variation
in humans
Many recent developments have enabled a rapid accumu-
lation of regulatory data in this fast advancing field. We
now know that human genomes contain thousands of cis-
regulatory variants (Rockman and Wray 2002) and con-
siderable differences in gene expression have been dem-
onstrated between individuals and populations (Cheung
et al. 2005; Stranger et al. 2007). For example the work of
Stranger et al. (2007) revealed 831 genes that displayed a
significant cis association in lymphoblastoid cells alone,
and the work of Ge and colleagues showed the phenome-
non to be extremely frequent and found several thousand
‘windows’ of imbalance of allelic expression (Ge et al.
2009). By considering genome wide SNP frequency, dis-
tributions in non-coding DNA, and patterns of conservation
it is now predicted that as much as 90% of the important
functional variation in the human genome may be regula-
tory (Goode et al. 2010). Cis-regulatory variants, which
have limited pleiotropic effects, are less likely to be dele-
terious than those acting in trans and are thus more likely
to be favoured in evolutionary adaptation. It is tempting to
speculate that because of the combinatorial nature of cis-
acting regulatory elements there will be many more
examples of soft selective sweeps, and it will be important
to develop techniques for their detection, since they may
otherwise be missed in genome wide association studies.
Some of these regulatory variants may have reached high
frequencies as a result of selection in our past, but may now
be responsible for present day disease susceptibilities.
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